CCN5 activation by free or encapsulated EGCG is required to render triple‐negative breast cancer cell viability and tumor progression

Epigallocatechin‐3‐gallate (EGCG) has been considered an anticancer agent despite conflicting and discrepant bioavailability views. EGCG impairs the viability and self‐renewal capacity of triple‐negative breast cancer (TNBC) cells and makes them sensitive to estrogen via activating ER‐α. Surprisingl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharmacol Res Perspect
Main Authors: Das, Amlan, Haque, Inamul, Ray, Priyanka, Ghosh, Arnab, Dutta, Debasmita, Quadir, Mohiuddin, De, Archana, Gunewardena, Sumedha, Chatterjee, Indranil, Banerjee, Snigdha, Weir, Scott, Banerjee, Sushanta K.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2021
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7981588/
https://ncbi.nlm.nih.gov/pubmed/33745223
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prp2.753
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados